top of page

INFItech Limited Showcases Innovative Brain Health Initiatives at ICPI WEEK 2025

On April 22, 2025, in Goyang, South Korea, INFItech Limited, a startup founded by a prestigious Hong Kong academic institution, showcased its innovative brain health-supporting products at ICPI WEEK 2025, Asia-Pacific’s largest biotechnology exhibition. Specializing in brain health maintenance, INFItech highlighted its proprietary “Cogniherbs” product series.


The event, spanning 60,124 square meters, hosted 1,200 exhibitors from 25 countries, showcasing cutting-edge biotechnology innovations. At KINTEX, INFItech’s booth attracted significant attention with two core technologies:

  1. Synaptic Function Support Technology: Backed by over two decades of research on synaptic plasticity and signal transmission, products have been tested rigourously in preclinical models with herbal optimization to ensure quality consistency. These products are designed for general wellness, offering innovative approaches to maintaining brain health.

  2. Innovative Herbal Formulations: Combining molecular neuroscience and Traditional Chinese Medicine (TCM), this cross-disciplinary research identified neuroprotective herbs from over 200 medicinal plants. These formulations suggest potential in support of memory and cognitive functions, providing a pioneering TCM-based approach.


“We integrate scientific interventions with Traditional Chinese Medicine,” said INFItech’s spokesperson. “Our technology, based on synaptic plasticity mechanisms, has led to the development of three novel formulations. Recently, investigator-initiated trials (IIT) have been proposed, aiming to deepen our understanding of interactions between the brain and natural products. These solutions may potentially promote brain health, offering promises for further applications.”

Through ICPI WEEK 2025, INFItech Limited successfully expanded its market, delivering innovative solutions to support patients’ quality of life and advance global brain health initiatives.










Comments


bottom of page